Published in Cytokine on January 10, 2013
Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy. Med Sci Monit (2015) 0.82
Effects of mir-21 on Cardiac Microvascular Endothelial Cells After Acute Myocardial Infarction in Rats: Role of Phosphatase and Tensin Homolog (PTEN)/Vascular Endothelial Growth Factor (VEGF) Signal Pathway. Med Sci Monit (2016) 0.75
Effects of Rosuvastatin and MiR-126 on Myocardial Injury Induced by Acute Myocardial Infarction in Rats: Role of Vascular Endothelial Growth Factor A (VEGF-A). Med Sci Monit (2016) 0.75
Novel Biomarker MicroRNAs for Subtyping of Acute Coronary Syndrome: A Bioinformatics Approach. Biomed Res Int (2016) 0.75
Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism. Front Pharmacol (2017) 0.75
Influence of dynamic training on hemodynamic, neurohormonal responses to static exercise and on inflammatory markers in patients after coronary artery bypass grafting. Circ J (2010) 2.09
Trends in heart failure mortality in Poland between 1980 and 2010. Pol Arch Med Wewn (2013) 2.04
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. J Clin Lipidol (2013) 1.58
Transcatheter aortic valve implantation using transfemoral/transsubclavian or transapical approach: 30-day follow-up of the initial 30 patients. Kardiol Pol (2011) 1.46
Impact of MTHFR C677T gene polymorphism and vitamins intake on homocysteine concentration in the Polish adult population. Kardiol Pol (2011) 1.44
Mortality from ischaemic heart disease in Poland in 1991-1996 estimated by the coding system used since 1997. Kardiol Pol (2010) 1.43
Does contrast agent injection during trans-catheter aortic valve implantation negatively affect kidney function? Kardiol Pol (2011) 1.41
Early implementation of continuous venovenous haemodiafiltration improves outcome in patients with heart failure complicated by acute kidney injury. Kardiol Pol (2011) 1.41
Prognostic value of novel biomarkers compared with detailed biochemical evaluation in patients with heart failure. Pol Arch Med Wewn (2015) 1.41
Inflammatory response and postoperative kidney failure in patients with diabetes type 2 or impaired glucose tolerance undergoing heart valve surgery. Kardiol Pol (2010) 1.40
Ischaemia modified albumin in patients with acute coronary syndrome and negative cardiac troponin I. Scand J Clin Lab Invest (2013) 1.39
Knowledge about arterial hypertension in the Polish population: the WOBASZ study. Kardiol Pol (2012) 1.39
[Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience]. Kardiol Pol (2012) 1.39
The role of B-type natriuretic peptide in the evaluation of left atrioventricular valve regurgitation following surgical repair of partial atrioventricular canal. Kardiol Pol (2012) 1.38
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J (2008) 1.19
A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence. Eur J Heart Fail (2009) 1.07
Incidence of diabetes in the Polish population: results of the Multicenter Polish Population Health Status Study--WOBASZ. Pol Arch Med Wewn (2011) 1.02
Right heart perforation by pacemaker leads. Arch Med Sci (2012) 0.95
Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J Hypertens (2007) 0.94
[Multicenter national Polish population health status tests--WOBASZ project. Establishment of methods and logistics]. Kardiol Pol (2005) 0.88
Decreased plasma concentration of a novel anti-inflammatory protein--adiponectin--in hypertensive men with coronary artery disease. Thromb Res (2003) 0.88
Alteration of myocardial sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger expression in human left ventricular volume overload. Eur J Heart Fail (2007) 0.87
Antioxidative activity of sulodexide, a glycosaminoglycan, in patients with stable coronary artery disease: a pilot study. Med Sci Monit (2009) 0.86
[New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland. Polish Cardiac Society statement]. Kardiol Pol (2011) 0.85
Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome. Growth Factors (2010) 0.85
The relationship between resting heart rate and atherosclerosis risk factors. Kardiol Pol (2008) 0.85
Multi-centre National Population Health Examination Survey (WOBASZ II study): assumptions, methods, and implementation. Kardiol Pol (2015) 0.85
The impact of early menopause on risk of coronary artery disease (PREmature Coronary Artery Disease In Women--PRECADIW case-control study). Eur J Prev Cardiol (2011) 0.84
Influence of renin-angiotensin system gene polymorphisms on the risk of ST-segment-elevation myocardial infarction and association with coronary artery disease risk factors. Mol Diagn Ther (2011) 0.84
Reduced myocardial expression of calcium handling protein in patients with severe chronic mitral regurgitation. Eur J Cardiothorac Surg (2006) 0.84
Adrenomedullin concentrations at two time points following myocardial infarction and prediction of mid-term outcomes. Arch Med Sci (2011) 0.83
Feasibility of home-based cardiac telerehabilitation: Results of TeleInterMed study. Cardiol J (2014) 0.82
Transcatheter pulmonary valve implantation in patients with right ventricular outflow tract dysfunction: early and mid-term results. J Invasive Cardiol (2015) 0.82
Ten-year risk of fatal cardiovascular disease in the Polish population and medical care. Results of the WOBASZ study. Kardiol Pol (2010) 0.82
Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. Eur Heart J (2010) 0.82
Effect of protein convertase subtilisin/kexin type 9 (PCSK9) 46L gene polymorphism on LDL cholesterol concentration in a Polish adult population. Mol Genet Metab (2008) 0.81
Severe chronic heart failure in patients considered for heart transplantation in Poland. Cardiol J (2012) 0.80
[Optimal model of comprehensive rehabilitation and secondary prevention]. Kardiol Pol (2013) 0.80
Significance of dyslipidaemia in patients with heart failure of unexplained aetiology. Kardiol Pol (2008) 0.80
Characterization of insomnia in patients with essential hypertension. Blood Press (2006) 0.80
Is the decrease of cardiovascular mortality in Poland associated with the reduction of global cardiovascular risk related to changes in life style? Kardiol Pol (2003) 0.80
Myocardial iron homeostasis in advanced chronic heart failure patients. Int J Cardiol (2011) 0.79
[Level of angiotensin II and aldosterone in plasma is often elevated in patients with heart failure treated with converting enzyme inhibitors--preliminary results]. Przegl Lek (2002) 0.79
Did favourable trends in food consumption observed in the 1984-2001 period contribute to the decrease in cardiovascular mortality? - Pol-MONICA Warsaw Project. Kardiol Pol (2006) 0.78
Usefulness of endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty. Am J Cardiol (2002) 0.78
Alterations in calcium regulatory protein expression in patients with preserved left ventricle systolic function and mitral valve stenosis. J Card Fail (2008) 0.78
[Awareness of guidelines for cardiovascular disease prevention among the adult population in Poland. Results of the WOBASZ program]. Kardiol Pol (2005) 0.78
Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension. Endokrynol Pol (2013) 0.78
Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography. Neuroendocrinology (2015) 0.77
Clinically overt and silent cerebral embolism in the course of infective endocarditis. J Neurol (2011) 0.77
Transcatheter aortic valve implantation in patients with bicuspid aortic valve: a series of cases. Kardiol Pol (2015) 0.77
Quality of nutrition and health knowledge in subjects with diagnosed cardio-vascular diseases in the Polish population--National Multicentre Health Survey (WOBASZ). Kardiol Pol (2008) 0.77
Familial dilated cardiomyopathy: evidence for clinical and immunogenetic heterogeneity. Med Sci Monit (2003) 0.77
Application of classic heart failure definitions of asymptomatic and symptomatic ventricular dysfunction and heart failure symptoms with preserved ejection fraction to patients with systemic right ventricles. Am J Cardiol (2009) 0.77
Tobacco smoking in Poland in the years from 2003 to 2014. Multi‑centre National Population Health Examination Survey (WOBASZ). Pol Arch Intern Med (2017) 0.77
The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease. Kardiol Pol (2003) 0.76
Clustering of admission hyperglycemia, impaired renal function and anemia and its impact on in-hospital outcomes in patients with ST-elevation myocardial infarction. Atherosclerosis (2009) 0.76
Gender differences in angiotensin II and aldosterone secretion in patients with pressure overloaded systemic right ventricles are similar to those observed in systemic arterial hypertension. Int J Cardiol (2009) 0.76
[A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population]. Kardiol Pol (2015) 0.76
Serum tissue inhibitor of metalloproteinases-1 and higher risk features of coronary plaque: a volumetric multivessel intravascular ultrasound study. Atherosclerosis (2006) 0.76
Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study. Pol Arch Med Wewn (2016) 0.75
Vascular complications after transcatheter aortic valve implantation (TAVI): risk and long-term results. J Thromb Thrombolysis (2014) 0.75
[Not Available]. Kardiol Pol (2012) 0.75
[Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum]. Kardiol Pol (2013) 0.75
[New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland - authors' reply]. Kardiol Pol (2012) 0.75
Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary study. BMC Cardiovasc Disord (2013) 0.75
Method of variability optimization in pharmacokinetic data analysis. Eur J Drug Metab Pharmacokinet (2013) 0.75
Hepatocyte growth factor concentration during the first day of acute coronary syndrome. Arch Med Sci (2012) 0.75
Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry. Kardiol Pol (2015) 0.75
Current patterns of antithrombotic and revascularization therapy in patients hospitalised for acute coronary syndromes. Data from the Polish Subset of the EPICOR Study. Kardiol Pol (2017) 0.75
Neutral endopeptidase activity is not elevated in serum in children with cholestatic liver disease: a unique role of aminopeptidase-m in sequential hydrolysis of peptides. Dig Dis Sci (2002) 0.75
Brain natriuretic peptide plasma levels in ischemic and nonischemic advanced heart failure. Acta Cardiol (2004) 0.75
[Severe hypercholesterolaemia - when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement]. Kardiol Pol (2016) 0.75
Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry. Kardiol Pol (2014) 0.75
Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum. Pol Arch Med Wewn (2013) 0.75
Polymorphisms of angiotensin II type 1 receptor gene and those of angiotensinogen point at culprit artery in ST-segment elevation myocardial infarction. Gene (2012) 0.75
Right pulmonary artery aplasia with coronary collaterals supplying a hypoplastic lung. Kardiol Pol (2013) 0.75
[Dental cardio common position for dealing anticoagulation in patients undergoing dental procedures]. Kardiol Pol (2016) 0.75
[Contemporary imaging of infective endocarditis. Part 1. Echocardiography. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging]. Kardiol Pol (2013) 0.75
The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism. Kardiol Pol (2003) 0.75
A severe complication after ST-segment elevation myocardial infarction (Part 1). Med Sci Monit (2011) 0.75
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy]. Kardiol Pol (2012) 0.75
Hepatocyte growth factor - the earliest marker of myocardial injury in ST-segment elevation myocardial infarction. Kardiol Pol (2013) 0.75
Comparison of mid-term results of transcatheter aortic valve implantation in high-risk patients with logistic EuroSCORE ≥ 20% or < 20. Kardiol Pol (2015) 0.75
Novel markers of cerebral embolism in the course of infective endocarditis. Int J Cardiol (2011) 0.75
Ten-year experience of an invasive cardiology centre with out-of-hospital cardiac arrest patients admitted for urgent coronary angiography. Kardiol Pol (2014) 0.75
A severe complication after ST-segment elevation myocardial infarction (Part 2). Med Sci Monit (2011) 0.75
Coronary artery fistula in a 70 year-old woman with myocardial infarction. Kardiol Pol (2011) 0.75
[Moderate or severe aquired valvular heart disease in pregnancy--what does determine the management? Experence, intuition or guidelines?]. Przegl Lek (2015) 0.75